Regeneron Pharmaceuticals (REGN) Earnings Report Date & History

Out of the last 100 earnings reporting periods, Regeneron Pharmaceuticals beat analysts’ expectations 83 times and fell short of expectations 16 time(s). Regeneron Pharmaceuticals reported earnings per share of $ 20.07 in the last report surpassing an estimated EPS of $ 16.51 by 21.56%.

Regeneron Pharmaceuticals’s stock was trading at $ 818.77 on Oct 29, 2026 a day before the last earnings report was released.Following the release of the earnings report, REGN’s price increased to $ 961.26 on Oct 31, 2026, recording a 17.40% price change in the 48-hour period.

When does Regeneron Pharmaceuticals (REGN) report earnings?

Regeneron Pharmaceuticals released its most recent earnings reports in October 2026, July 2026, April 2026, January 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.

What is the next Regeneron Pharmaceuticals (REGN) earnings date?

The next Regeneron Pharmaceuticals earnings date is expected for January 2027. Generally, most companies have a consistent schedule for their earnings releases. For example, they might release their quarterly earnings within a few weeks after the end of each quarter. However, there can be variations due to various factors, including unexpected events, changes in business circumstances, or other reporting requirements.

What is Regeneron Pharmaceuticals (REGN) stock EPS forecast?

Regeneron Pharmaceuticals beat analysts’ expectations during the last earnings period by 21.56%. Regeneron Pharmaceuticals reported earnings of $ 20.07 per share on Oct 30, 2026, while the forecasted EPS was $ 16.51